PL1697343T3 - Aminobenzimidazole i benzimidazole jako inhibitory replikacji wirusa oddechowego - Google Patents

Aminobenzimidazole i benzimidazole jako inhibitory replikacji wirusa oddechowego

Info

Publication number
PL1697343T3
PL1697343T3 PL04804949T PL04804949T PL1697343T3 PL 1697343 T3 PL1697343 T3 PL 1697343T3 PL 04804949 T PL04804949 T PL 04804949T PL 04804949 T PL04804949 T PL 04804949T PL 1697343 T3 PL1697343 T3 PL 1697343T3
Authority
PL
Poland
Prior art keywords
aminobenzimidazoles
benzimidazoles
inhibitors
respiratory syncytial
syncytial virus
Prior art date
Application number
PL04804949T
Other languages
English (en)
Inventor
Jean-François Bonfanti
Koenraad Jozef Lodewijk Andries
Jérôme Michel Claude Fortin
Philippe Muller
Frédéric Marc Maurice Doublet
Christophe Meyer
Rudy Edmond Willebrords
Tom Valerius Josepha Gevers
Philip Maria Martha Bern Timmerman
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of PL1697343T3 publication Critical patent/PL1697343T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL04804949T 2003-12-18 2004-12-20 Aminobenzimidazole i benzimidazole jako inhibitory replikacji wirusa oddechowego PL1697343T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP03104797 2003-12-18
US56683404P 2004-04-30 2004-04-30
PCT/EP2004/053613 WO2005058869A1 (en) 2003-12-18 2004-12-20 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication
EP04804949A EP1697343B1 (en) 2003-12-18 2004-12-20 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication

Publications (1)

Publication Number Publication Date
PL1697343T3 true PL1697343T3 (pl) 2009-12-31

Family

ID=34924148

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04804949T PL1697343T3 (pl) 2003-12-18 2004-12-20 Aminobenzimidazole i benzimidazole jako inhibitory replikacji wirusa oddechowego

Country Status (19)

Country Link
US (1) US8044073B2 (pl)
EP (1) EP1697343B1 (pl)
JP (1) JP4915734B2 (pl)
CN (1) CN1918146B (pl)
AR (1) AR046971A1 (pl)
AT (1) ATE435222T1 (pl)
AU (1) AU2004298457B2 (pl)
BR (1) BRPI0417811A (pl)
CA (1) CA2548657A1 (pl)
DK (1) DK1697343T3 (pl)
ES (1) ES2328700T3 (pl)
MY (1) MY141292A (pl)
NZ (1) NZ547796A (pl)
PL (1) PL1697343T3 (pl)
PT (1) PT1697343E (pl)
RU (1) RU2379302C2 (pl)
TW (1) TWI356055B (pl)
WO (1) WO2005058869A1 (pl)
ZA (1) ZA200605893B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR046959A1 (es) * 2003-12-18 2006-01-04 Tibotec Pharm Ltd Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio
CA2612263C (en) 2005-06-20 2015-04-14 Tibotec Pharmaceuticals Ltd. 1-(2-amino-3-(substituted alkyl)-3h-benzimidazolylmethyl)-3-subtituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus
DE602007012308D1 (de) 2006-12-22 2011-03-10 Avexa Ltd Bicyclische pyrimidinone und deren verwendung
CA2864825C (en) 2012-02-17 2021-01-26 Abbvie Inc. Diaminopyrimidines useful as inhibitors of the human respiratory syncytial virus (rsv)
HK1225716A1 (zh) 2013-08-21 2017-09-15 Alios Biopharma, Inc. 抗病毒化合物
MA41614A (fr) 2015-02-25 2018-01-02 Alios Biopharma Inc Composés antiviraux
TW201825465A (zh) 2016-09-23 2018-07-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201813963A (zh) 2016-09-23 2018-04-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201815787A (zh) 2016-09-23 2018-05-01 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
PT3448859T (pt) 2017-03-20 2019-10-25 Forma Therapeutics Inc Composições de pirrolopirrole como ativadores de piruvato quinase (pkr).
WO2019067864A1 (en) 2017-09-29 2019-04-04 Enanta Pharmaceuticals, Inc. PHARMACEUTICAL AGENTS IN COMBINATION AS INHIBITORS OF RSV
EP3594205A1 (en) 2018-07-09 2020-01-15 Abivax Phenyl-n-aryl derivatives for treating a rna virus infection
EP3594206A1 (en) 2018-07-09 2020-01-15 Abivax Phenyl-n-quinoline derivatives for treating a rna virus infection
ES2989438T3 (es) 2018-09-19 2024-11-26 Novo Nordisk Healthcare Ag Activación de la piruvato cinasa R
US12053458B2 (en) 2018-09-19 2024-08-06 Novo Nordisk Health Care Ag Treating sickle cell disease with a pyruvate kinase R activating compound
CN114615977B (zh) 2019-09-19 2025-01-14 诺沃挪第克健康护理股份公司 丙酮酸激酶r(pkr)活化组合物
US12128035B2 (en) 2021-03-19 2024-10-29 Novo Nordisk Health Care Ag Activating pyruvate kinase R

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE31812B1 (en) * 1967-02-03 1973-01-10 Merck & Co Inc Benzimidazole derivatives
US4179505A (en) * 1977-03-30 1979-12-18 Janssen Pharmaceutica N.V. 5-[4-(Diarylmethyl)-1-piperazinylalkyl]benzimidazole derivatives
CA1140119A (en) 1978-04-03 1983-01-25 Joseph Torremans N-heterocyclyl-4-piperidinamines
US4492708A (en) * 1982-09-27 1985-01-08 Eli Lilly And Company Antiviral benzimidazoles
KR100190299B1 (ko) 1990-07-19 1999-06-01 디르크 반테 신규한 옥사졸릴 유도체
WO1995003298A1 (en) 1993-07-19 1995-02-02 Fujisawa Pharmaceutical Co., Ltd. BENZIMIDAZOLE DERIVATIVES USEFUL AS DOPAMINE RECEPTOR ANTAGONIST, 5-HT RECEPTOR AGONIST OR α1 RECEPTOR ANTAGONIST
US5545653A (en) * 1995-06-07 1996-08-13 Eli Lilly And Company Anti-viral compounds
CA2227688C (en) * 1998-01-16 2007-07-31 James W. Critchfield Methods and compositions for inhibition of viral replication
CZ20014573A3 (cs) * 1999-06-28 2002-05-15 Janssen Pharmaceutica N. V. Inhibitory replikace respiračně syncyciálního viru
CA2376781A1 (en) * 1999-06-28 2001-01-04 Janssen Pharmaceutica N.V. Benzimidazoles and imidazopyridines as respiratory syncytial virus replication inhibitors
EA005027B1 (ru) * 1999-06-28 2004-10-28 Янссен Фармацевтика Н.В. Ингибиторы репликации респираторно-синцитиального вируса
WO2002090347A1 (en) * 2001-04-30 2002-11-14 Fujisawa Pharmaceutical Co., Ltd. Amide compounds
US7030150B2 (en) * 2001-05-11 2006-04-18 Trimeris, Inc. Benzimidazole compounds and antiviral uses thereof
FR2833948B1 (fr) * 2001-12-21 2004-02-06 Sod Conseils Rech Applic Nouveaux derives de benzimidazole et leur utilisation en tant que medicament

Also Published As

Publication number Publication date
ATE435222T1 (de) 2009-07-15
JP2007514717A (ja) 2007-06-07
CA2548657A1 (en) 2005-06-30
AU2004298457B2 (en) 2010-05-27
AU2004298457A1 (en) 2005-06-30
TW200602327A (en) 2006-01-16
EP1697343A1 (en) 2006-09-06
PT1697343E (pt) 2009-09-16
RU2006125726A (ru) 2008-01-27
AR046971A1 (es) 2006-01-04
NZ547796A (en) 2009-04-30
CN1918146A (zh) 2007-02-21
US8044073B2 (en) 2011-10-25
ZA200605893B (en) 2007-11-28
ES2328700T3 (es) 2009-11-17
US20070099924A1 (en) 2007-05-03
JP4915734B2 (ja) 2012-04-11
WO2005058869A1 (en) 2005-06-30
CN1918146B (zh) 2011-09-14
EP1697343B1 (en) 2009-07-01
TWI356055B (en) 2012-01-11
BRPI0417811A (pt) 2007-03-27
RU2379302C2 (ru) 2010-01-20
MY141292A (en) 2010-04-16
DK1697343T3 (da) 2009-10-05

Similar Documents

Publication Publication Date Title
TWI349007B (en) Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
EG25799A (en) Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication
IL183652A0 (en) Respiratory devices and methods of use
ZA200605893B (en) Aminobenzimidazones and benzimidazoles as inhibitors of respiratory syncytial virus replication
IL198397A0 (en) Anilinopiperazine derivatives and methods of use thereof
IL189080A0 (en) Substituted benzimidazoles and methods of preparation
EP2021455A4 (en) SYSTEM FOR PREPARING CYTOBLOCS AND METHODS OF USE THEREOF
EP1827391A4 (en) DOSAGE FORMS AND METHODS OF USE THEREOF
IL192053A (en) 2-Admentiluria derivatives as selective inhibitors of 1hsd-β11 and their use in drug preparation
IL180488A0 (en) Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof of kinase inhibitors
EP2054063A4 (en) 4-AMINOCHINAZOLINE DERIVATIVES AND METHOD FOR THEIR USE
IL182734A0 (en) 4-aminotetracyclines and methods of use thereof
IL184735A0 (en) Pharmaceutical formulations and methods of use
ZA200808017B (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
EP1797186A4 (en) EXPRESSION SYSTEM, COMPONENTS OF THIS EXPRESSION SYSTEM, AND METHODS OF USE
EP1817277A4 (en) PHENYL DERIVATIVES AND METHOD OF USE
MY142783A (en) 5-or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
ZA200609141B (en) Compositions for Inhalation therapy and methods of use
EP1812451A4 (en) COMPOUNDS AND METHODS OF USE THEREOF
EP1885381A4 (en) PHARMACEUTICAL USE OF GRAPTOPETALUM AND RELATED PLANTS
EP1883404A4 (en) P38 INHIBITORS AND METHODS OF USE
IL176063A0 (en) Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication
SI1723136T1 (sl) Piperidin-amino-benzimidazolni derivati kot inhibitorji replikacije respiratornega sincicijskega virusa
HK1095588A (en) Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication
ZA200800536B (en) Substituted benzimidazoles and methods of preparation